Biocon Biologics

Biocon Biologics | A Pharmaceutical Powerhouse in the Making #bioconshare #stockmarketindia

Krish Kothari (Sensei Kujaku)

Biocon Biologics: on a mission to unlock universal access to rh-insulin

Shreehas Tambe CEO & MD Biocon Biologics on 'ET Now ON THE GO'

Biocon Biologics

Reporter's Take | Biocon Biologics raises Rs 530 crore at steep $3 bn valuation

Biocon Biologics Presents #StoriesofHope: Melvin George

Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO

CNBC International News

Biocon Biologics Global Scale Capabilities

Biocon Biologics

Biocon Biologics Receives FDA Approval for YESAFILI, Enters US Ophthalmology Market

Biocon: ALZUMAb launched in India - First in Class Novel Biologic Treatment for Psoriasis

Biocon Biologics (Brand Film)

Biocon Biologics: Strong Earnings In Q2, What's Expansion & Capex Utilisation Plans?; Shreehas Tambe

Decoding Biocon Biologics’ Growth Trajectory | Opportunity In Multi-Billion Dollar Biosimilar Space

Biocon Biologics' transformational milestones in 2022.

Biocon Biologics

Biocon Biologics Restructures Deal With SII | Nithya Balasubramanian Speaks On This & More

Biocon Bangalore 483's July 2024 USFDA Inspection | Learning through 483 Observations

Biocon Biologics: Revolutionizing Healthcare with Biosimilars

Biocon Biologics

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics speaking on Q2 FY25 Results

CBI arrests Biocon Biologics' AVP over allegations of bribery